Archeon Medical Secures $9M (€7.5M) Series A to Advance Clinical Validation of Ventilation System for Cardiac Arrest Patients

Funding will accelerate US scale-up of EOlife®, a real-time ventilation feedback device designed to improve cardiac arrest resuscitation survival and neurological outcomes. Validation of EU and US clinical studies involving 1,500+ real-world cardiac arrest patients is key to global expansion and the ambition to set a new worldwide standard for emergency care in cardiac arrest